-
Product Insights
NewQuarterly Hot Coffee pricing trends in China
Empower your strategies with our Quarterly Hot Coffee pricing trends in China report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
NewQuarterly Condiment Sauces pricing trends in Australia
Empower your strategies with our Quarterly Condiment Sauces pricing trends in Australia report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
NewQuarterly Chocolate pricing trends in China
Empower your strategies with our Quarterly Chocolate pricing trends in China report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Sector Analysis
Lebanon Insurance Industry – Key Trends and Opportunities to 2028
Lebanon Insurance Market Report Overview The gross written premium of the Lebanon insurance market was LBP5.1 trillion ($81.5 million) in 2023. The market is expected to achieve a CAGR of more than 42% during 2024-2028. The Lebanon insurance market research report provides a detailed outlook by product category for the Lebanon insurance industry. Lebanon Insurance Market Outlook, 2023-2028 (LBP Trillion) Buy the Full Report for More Insights into the Lebanon Insurance Market Forecast Download a Free Report Sample The Lebanon...
-
Product Insights
Sal de Vida Project
The Sal de Vida Project is a lithium project in Argentina. It is currently under construction. Empower your strategies with our Sal de Vida Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ozempic in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ozempic in Acute Ischemic Stroke report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ozempic in Acute Ischemic Stroke Drug Details: Semaglutide (Ozempic /...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rintatolimod in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rintatolimod in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rintatolimod in Triple-Negative Breast Cancer (TNBC) Drug Details: Ampligen...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SAL-007 in Systolic Heart Failure
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. SAL-007 in Systolic Heart Failure Drug Details: JK-07 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Axitinib in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Axitinib in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Axitinib in Non-Small Cell Lung Cancer Drug Details: Axitinib (Inlyta)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – 7HP-349 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. 7HP-349 in Solid Tumor Drug Details: 7HP-349 is under development for the treatment of metastatic...